Imatinib Improves Exercise Capacity and Hemodynamics at 24 Weeks as Add-on Therapy in Symptomatic Pulmonary Arterial Hypertension Patients: The IMPRES Study
暂无分享,去创建一个
H. Ghofrani | R. Barst | A. Frost | G. Simonneau | M. Hoeper | P. Hassoun | V. Tapson | T. Satoh | F. Torres | R. Bourge | A. Peacock | N. Galiè | N. Morrell | E. Gruenig | D. Quinn | Keith Liu | M. Sánchez | J. Feldman